Is Cyclacel Pharmaceuticals, Inc. (CYCC) a Buy, Sell, or Hold?
Cyclacel Pharmaceuticals, Inc.
NASDAQ:CYCC
$6.365 USD
-$0.41 (-5.98%)
- Volume
- 219.91K
- Average Volume
- 1.81M
- Market Capitalization
- $10.61M
- P/E Ratio
- -26.54
- Dividend Yield
- 0.00%
- Price Target
- $1.00
- Year High
- $597.60
- Year Low
- $3.08
- Day High
- —
- Day Low
- —
- Payout Ratio
- $-0.03
- Current Ratio
- $7.06
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
11
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
7
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 197.94M
CYCC Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
CYCC Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Kua Khai Loon | 10 percent owner | 2025-09-05 | S-Sale | 7.01 | 2025-09-10 |
| Yap Kim Choy | 10 percent owner | 2025-09-04 | J-Other | 0 | 2025-09-04 |
| Yap Kim Choy | 10 percent owner | 2025-09-04 | J-Other | 10.2 | 2025-09-04 |
| Kua Khai Loon | 10 percent owner | 2025-09-04 | J-Other | 0 | 2025-09-04 |
| Kua Khai Loon | 10 percent owner | 2025-09-04 | J-Other | 10.2 | 2025-09-04 |
| Ong Yee Lung | 10 percent owner | 2025-09-04 | J-Other | 0 | 2025-09-04 |
| Ong Yee Lung | 10 percent owner | 2025-09-04 | J-Other | 10.2 | 2025-09-04 |
| Ong Yee Lung | 10 percent owner | 2025-09-01 | 0 | 2025-09-02 | |
| Ong Yee Lung | 10 percent owner | 2025-06-20 | 10.2 | 2025-09-02 | |
| Ong Yee Lung | 10 percent owner | 2025-06-20 | 9 | 2025-09-02 | |
| Ong Yee Lung | 10 percent owner | 2025-06-20 | 7.65 | 2025-09-02 | |
| Kua Khai Loon | 10 percent owner | 2025-09-01 | 0 | 2025-09-02 | |
| Kua Khai Loon | 10 percent owner | 2025-06-20 | 10.2 | 2025-09-02 | |
| Kua Khai Loon | 10 percent owner | 2025-06-20 | 7.65 | 2025-09-02 | |
| Kua Khai Loon | 10 percent owner | 2025-06-20 | 9 | 2025-09-02 | |
| Yap Kim Choy | 10 percent owner | 2025-09-01 | 0 | 2025-09-02 | |
| Yap Kim Choy | 10 percent owner | 2025-06-20 | 10.2 | 2025-09-02 | |
| Yap Kim Choy | 10 percent owner | 2025-06-20 | 7.65 | 2025-09-02 | |
| Yap Kim Choy | 10 percent owner | 2025-06-20 | 9 | 2025-09-02 | |
| Lazar David E. | 10 percent owner | 2025-07-30 | S-Sale | 12.36 | 2025-08-04 |
| Tan Kok Hui | 2025-04-29 | 0 | 2025-05-30 | ||
| SURIA SUKSES ENGINEERING SDN BHD | 2025-04-29 | 0 | 2025-05-30 | ||
| Ho Kee Wee | 2025-04-29 | 0 | 2025-05-30 | ||
| Ho Jien Shiung | 2025-04-29 | 0 | 2025-05-30 | ||
| Ho Jien Shiung | 10 percent owner | 2025-04-29 | 0 | 2025-05-15 | |
| Ho Kee Wee | 10 percent owner | 2025-04-29 | 0 | 2025-05-15 | |
| Tan Kok Hui | 10 percent owner | 2025-04-29 | 0 | 2025-05-14 | |
| Laurduraj Inigo Angel | director | 2025-04-02 | 0 | 2025-05-02 | |
| SURIA SUKSES ENGINEERING SDN BHD | 10 percent owner | 2025-04-29 | 0 | 2025-05-02 | |
| Nair Krishnan Satis Waran | director | 2025-04-02 | 0 | 2025-05-02 | |
| NATAN DAVID | director | 2025-02-26 | A-Award | 0.33 | 2025-02-28 |
| Lazar David E. | 10 percent owner, officer: Interim CEO | 2025-02-26 | M-Exempt | 0 | 2025-02-28 |
| Lazar David E. | 10 percent owner, officer: Interim CEO | 2025-02-26 | M-Exempt | 0 | 2025-02-28 |
| Lazar David E. | 10 percent owner, officer: Interim CEO | 2025-02-26 | M-Exempt | 0 | 2025-02-28 |
| Lazar David E. | 10 percent owner, officer: Interim CEO | 2025-02-26 | M-Exempt | 0 | 2025-02-28 |
| Lazar David E. | 10 percent owner, officer: Interim CEO | 2025-02-26 | S-Sale | 0.0283 | 2025-02-28 |
| Ben-Tzvi Avraham | director | 2025-02-26 | A-Award | 0.33 | 2025-02-28 |
| Doris Wong Sing Ee | director, 10 percent owner, officer: Chief Executive Officer | 2025-02-26 | 0 | 2025-02-28 | |
| Chong Kwang Fock | director | 2025-02-26 | 0 | 2025-02-28 | |
| Kiu Cu Seng | director, officer: CFO and Secretary | 2025-02-26 | 0 | 2025-02-28 | |
| Lazar David E. | 10 percent owner, officer: Interim CEO | 2025-02-06 | A-Award | 0 | 2025-02-10 |
| Ben-Tzvi Avraham | director | 2025-01-05 | 0 | 2025-01-08 | |
| NATAN DAVID | director | 2025-01-02 | A-Award | 0 | 2025-01-07 |
| NATAN DAVID | director | 2025-01-02 | 0 | 2025-01-07 | |
| Lazar David E. | director, officer: Chief Executive Officer | 2025-01-02 | 0 | 2025-01-07 | |
| Lazar David E. | director, officer: Chief Executive Officer | 2025-01-02 | 0 | 2025-01-07 | |
| SCHWARTZ BRIAN | director, officer: Interim Chief Medical Officer | 2024-01-29 | A-Award | 0 | 2024-01-31 |
| SCHWARTZ BRIAN | director, officer: Interim Chief Medical Officer | 2024-01-29 | A-Award | 2.28 | 2024-01-31 |
| McBarron Paul | director, officer: See Remarks | 2023-12-21 | P-Purchase | 3.315 | 2023-12-26 |
| McBarron Paul | director, officer: See Remarks | 2023-12-21 | P-Purchase | 3.19 | 2023-12-26 |
| Rombotis Spiro George | director, officer: President and CEO | 2023-12-21 | P-Purchase | 3.315 | 2023-12-26 |
| Rombotis Spiro George | director, officer: President and CEO | 2023-12-21 | P-Purchase | 3.19 | 2023-12-26 |
| Rombotis Spiro George | director, officer: President and CEO | 2023-06-30 | A-Award | 0.5891 | 2023-07-03 |
| BARKER SAM L | director | 2023-06-30 | A-Award | 0.5891 | 2023-07-03 |
| BARKER SAM L | director | 2023-06-30 | A-Award | 0 | 2023-07-03 |
| Spiegel Robert J. | director | 2023-06-30 | A-Award | 0.5891 | 2023-07-03 |
| Spiegel Robert J. | director | 2023-06-30 | A-Award | 0 | 2023-07-03 |
| McBarron Paul | director, officer: See Remarks | 2023-06-30 | A-Award | 0.5891 | 2023-07-03 |
| Kirschbaum Mark | officer: Chief Medical Officer | 2023-06-30 | A-Award | 0.5891 | 2023-07-03 |
| Walker Karin L | director | 2023-06-30 | A-Award | 0.5891 | 2023-07-03 |
| Walker Karin L | director | 2023-06-30 | A-Award | 0 | 2023-07-03 |
| Ferguson Kenneth M. | director | 2023-06-30 | A-Award | 0 | 2023-07-03 |
| Ferguson Kenneth M. | director | 2023-06-30 | A-Award | 0.5891 | 2023-07-03 |
| HENNEY CHRISTOPHER S | director | 2023-06-30 | A-Award | 0.5891 | 2023-07-03 |
| HENNEY CHRISTOPHER S | director | 2023-06-30 | A-Award | 0 | 2023-07-03 |
| SCHWARTZ BRIAN | director | 2023-06-30 | A-Award | 0.5891 | 2023-07-03 |
| SCHWARTZ BRIAN | director | 2023-06-30 | A-Award | 0 | 2023-07-03 |
| McBarron Paul | director, officer: See Remarks | 2023-01-31 | A-Award | 0 | 2023-02-02 |
| Rombotis Spiro George | director, officer: President and CEO | 2023-01-31 | A-Award | 0 | 2023-02-02 |
| Kirschbaum Mark | officer: Chief Medical Officer | 2023-01-31 | A-Award | 0 | 2023-02-02 |
| Ferguson Kenneth M. | director | 2022-06-14 | A-Award | 1.11 | 2022-06-17 |
| Ferguson Kenneth M. | director | 2022-06-14 | A-Award | 0 | 2022-06-17 |
| Ferguson Kenneth M. | director: | 2022-06-14 | A-Award | 0 | 2022-06-16 |
| Ferguson Kenneth M. | director: | 2022-06-14 | 0 | 2022-06-16 | |
| Walker Karin L | director: | 2022-06-14 | A-Award | 0 | 2022-06-16 |
| Spiegel Robert J. | director: | 2022-06-14 | A-Award | 0 | 2022-06-16 |
| Sems Lloyd | director: | 2022-06-14 | A-Award | 0 | 2022-06-16 |
| SCHWARTZ BRIAN | director | 2022-06-14 | A-Award | 1.11 | 2022-06-16 |
| SCHWARTZ BRIAN | director: | 2022-06-14 | A-Award | 0 | 2022-06-16 |
| HENNEY CHRISTOPHER S | director | 2022-06-14 | A-Award | 1.11 | 2022-06-16 |
| HENNEY CHRISTOPHER S | director: | 2022-06-14 | A-Award | 0 | 2022-06-16 |
| HENNEY CHRISTOPHER S | director | 2022-06-14 | A-Award | 0 | 2022-06-16 |
| BARKER SAM L | director | 2022-06-14 | A-Award | 1.11 | 2022-06-16 |
| BARKER SAM L | director: | 2022-06-14 | A-Award | 0 | 2022-06-16 |
| Rombotis Spiro George | director, officer: President and CEO | 2021-12-13 | A-Award | 3.45 | 2021-12-16 |
| McBarron Paul | director, officer: See Remarks | 2021-12-13 | A-Award | 3.45 | 2021-12-15 |
| Kirschbaum Mark | officer: Chief Medical Officer | 2021-12-13 | A-Award | 3.45 | 2021-12-15 |
| BARKER SAM L | director | 2021-11-30 | S-Sale | 3.5716 | 2021-12-02 |
| Rombotis Spiro George | director, officer: President and CEO | 2021-11-18 | P-Purchase | 4.5 | 2021-11-22 |
| BARKER SAM L | director | 2021-08-24 | P-Purchase | 5 | 2021-08-25 |
| Hradsky Gregory T. | director | 2021-06-15 | A-Award | 6.69 | 2021-06-17 |
| Hradsky Gregory T. | director | 2021-06-15 | A-Award | 0 | 2021-06-17 |
| Sems Lloyd | director | 2021-06-15 | A-Award | 6.69 | 2021-06-17 |
| Sems Lloyd | director | 2021-06-15 | A-Award | 0 | 2021-06-17 |
| BARKER SAM L | director | 2021-06-15 | A-Award | 6.69 | 2021-06-17 |
| BARKER SAM L | director | 2021-06-15 | A-Award | 0 | 2021-06-17 |
| Spiegel Robert J. | director | 2021-06-15 | A-Award | 6.69 | 2021-06-17 |
| Spiegel Robert J. | director | 2021-06-15 | A-Award | 0 | 2021-06-17 |
| HENNEY CHRISTOPHER S | director | 2021-06-15 | A-Award | 6.69 | 2021-06-17 |
| HENNEY CHRISTOPHER S | director | 2021-06-15 | A-Award | 0 | 2021-06-17 |